Literature DB >> 19184932

Newcastle disease virus: macromolecules and opportunities.

K Yusoff, W S Tan.   

Abstract

Over the past two decades, enormous advances have occurred in the structural and biological characterization of Newcastle disease virus (NDV). As a result, not only the complete sequence of the viral genome has been fully determined, but also a clearer understanding of the viral proteins and their respective roles in the life cycle has been achieved. This article reviews the progress in the molecular biology of NDV with emphasis on the new technologies. It also identifies the fundamental problems that need to be addressed and attempts to predict some research opportunities in NDV that can be realized in the near future for the diagnosis, prevention and treatment of disease(s).

Entities:  

Year:  2001        PMID: 19184932     DOI: 10.1080/03079450120078626

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  41 in total

1.  Fusion and matrix protein gene sequence analysis of paramyxoviruses of type 1(PMV-1) isolated from pigeons in Slovenia.

Authors:  Darja Barlic-Maganja; Uros Krapez; Sara Mankoc; Ivan Toplak; Olga Zorman Rojs
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

2.  Activation of the extracellular signal-regulated kinase pathway is required for replication of Newcastle disease virus.

Authors:  Jie Ni; Shunlin Hu; Xiaoquan Wang; Xiaowen Liu; Zenglei Hu; Xiufan Liu
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

3.  Molecular Characterization of Thermostable Newcastle disease virus Isolated from Pigeon.

Authors:  A Uthrakumar; K Vijayarani; K Kumanan; V Thiagarajan
Journal:  Indian J Virol       Date:  2013-01-29

4.  Deduced amino acid sequences surrounding the fusion glycoprotein cleavage site and of the carboxyl-terminus of haemagglutinin-neuraminidase protein of the avirulent thermostable vaccine strain I-2 of Newcastle disease virus.

Authors:  P N Wambura; J Meers; J A Kattenbelt; A R Gould; P B Spradbrow
Journal:  Vet Res Commun       Date:  2006-12-29       Impact factor: 2.459

5.  Nucleotide and predicted amino acid sequence analysis of the fusion protein and hemagglutinin-neuraminidase protein genes among Newcastle disease virus isolates. Phylogenetic relationships among the Paramyxovirinae based on attachment glycoprotein sequences.

Authors:  Bruce S Seal
Journal:  Funct Integr Genomics       Date:  2004-04-24       Impact factor: 3.410

6.  Genomic comparison of the complete coding and intergenic regions of the VG/GA Newcastle disease virus and its respirotropic clone 5.

Authors:  Francisco Perozo; Pedro Villegas; Claudio L Afonso
Journal:  Virus Genes       Date:  2008-06-24       Impact factor: 2.332

7.  Protective efficacy of inactivated Newcastle disease virus vaccines prepared in two different oil-based adjuvants.

Authors:  Oday A Aljumaili; Muhammad B Bello; Swee K Yeap; Abdul R Omar; Aini Ideris
Journal:  Onderstepoort J Vet Res       Date:  2020-09-28       Impact factor: 1.792

8.  The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling.

Authors:  Wei-Choong Ch'ng; Eric J Stanbridge; Khatijah Yusoff; Norazizah Shafee
Journal:  J Interferon Cytokine Res       Date:  2013-03-18       Impact factor: 2.607

9.  An overview on the development of newcastle disease virus as an anti-cancer therapy.

Authors:  Abdul Rahman Omar; Aini Ideris; Abdul Manaf Ali; Fauziah Othman; Khatijah Yusoff; Jafri Malin Abdullah; Haryati Shila Mohamad Wali; Madihah Zawawi; Narayani Meyyappan
Journal:  Malays J Med Sci       Date:  2003-01

10.  Viable Newcastle disease vaccine strains in a pharmaceutical dump.

Authors:  Antonella Amendola; Silvia Bianchi; Marta Canuti; Alessandra Zappa; Giovanna Zanoni; Raffaella Koncan; Elisabetta Tanzi; Giuseppe Cornaglia; Alessandro Remo Zanetti; Giuseppe Tridente
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.